These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35811843)

  • 21. Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice.
    Singh AB; Dong B; Kraemer FB; Xu Y; Zhang Y; Liu J
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2448-2459. PubMed ID: 30354208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen stimulates SREBP2 expression in hepatic cell lines via an estrogen response element in the SREBP2 promoter.
    Meng Y; Zong L
    Cell Mol Biol Lett; 2019; 24():65. PubMed ID: 31827541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic NPC1L1 promotes hyperlipidemia in LDL receptor deficient mice.
    Wang Y; Tang W; Yang P; Shin H; Li Q
    Biochem Biophys Res Commun; 2018 May; 499(3):626-633. PubMed ID: 29601818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression.
    Duan Y; Chen Y; Hu W; Li X; Yang X; Zhou X; Yin Z; Kong D; Yao Z; Hajjar DP; Liu L; Liu Q; Han J
    J Biol Chem; 2012 Jul; 287(28):23667-77. PubMed ID: 22593575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Inflammatory Effects of Ang-(1-7) in Ameliorating HFD-Induced Renal Injury through LDLr-SREBP2-SCAP Pathway.
    Zheng Y; Tang L; Huang W; Yan R; Ren F; Luo L; Zhang L
    PLoS One; 2015; 10(8):e0136187. PubMed ID: 26291618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of low density lipoprotein receptor expression by long-term exposure to phorbol ester via p38 mitogen-activated protein kinase pathway.
    Oh J; Choi YS; Kim JW; Park JY; Kim SW; Park KK; Pak YK
    J Cell Biochem; 2005 Nov; 96(4):786-94. PubMed ID: 16149074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IDOL, inducible degrader of low-density lipoprotein receptor, serves as a potential therapeutic target for dyslipidemia.
    Zhang CP; Tian Y; Zhang M; Tuo QH; Chen JX; Liao DF
    Med Hypotheses; 2016 Jan; 86():138-42. PubMed ID: 26601593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cloning and partial characterization of an ovarian receptor with seven ligand binding repeats, an orthologue of low-density lipoprotein receptor, in the cutthroat trout (Oncorhynchus clarki).
    Luo W; Ito Y; Mizuta H; Massaki K; Hiramatsu N; Todo T; Reading BJ; Sullivan CV; Hara A
    Comp Biochem Physiol A Mol Integr Physiol; 2013 Oct; 166(2):263-71. PubMed ID: 23827521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The elevation of miR-185-5p alleviates high-fat diet-induced atherosclerosis and lipid accumulation
    Tan W; Wang G; Liu G; You D; Wei M; Jin X; Zhao W; Zheng M
    Aging (Albany NY); 2022 Feb; 14(4):1729-1742. PubMed ID: 35172278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quercetin up-regulates LDL receptor expression in HepG2 cells.
    Moon J; Lee SM; Do HJ; Cho Y; Chung JH; Shin MJ
    Phytother Res; 2012 Nov; 26(11):1688-94. PubMed ID: 22388943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alginate oligosaccharide enhances LDL uptake via regulation of LDLR and PCSK9 expression.
    Yang JH; Bang MA; Jang CH; Jo GH; Jung SK; Ki SH
    J Nutr Biochem; 2015 Nov; 26(11):1393-400. PubMed ID: 26320675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Welsh onion extract inhibits PCSK9 expression contributing to the maintenance of the LDLR level under lipid depletion conditions of HepG2 cells.
    Choi HK; Hwang JT; Nam TG; Kim SH; Min DK; Park SW; Chung MY
    Food Funct; 2017 Dec; 8(12):4582-4591. PubMed ID: 29130084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delineation of molecular pathways that regulate hepatic PCSK9 and LDL receptor expression during fasting in normolipidemic hamsters.
    Wu M; Dong B; Cao A; Li H; Liu J
    Atherosclerosis; 2012 Oct; 224(2):401-10. PubMed ID: 22954675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lecithin:cholesterol acyltransferase deficiency protects against cholesterol-induced hepatic endoplasmic reticulum stress in mice.
    Hager L; Li L; Pun H; Liu L; Hossain MA; Maguire GF; Naples M; Baker C; Magomedova L; Tam J; Adeli K; Cummins CL; Connelly PW; Ng DS
    J Biol Chem; 2012 Jun; 287(24):20755-68. PubMed ID: 22500017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of leptin on the expression of low density lipoprotein receptor.
    Yadav NK; Arjuman A; Chandra NC
    Indian J Med Res; 2014 Oct; 140(4):524-30. PubMed ID: 25488447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements.
    Li H; Chen W; Zhou Y; Abidi P; Sharpe O; Robinson WH; Kraemer FB; Liu J
    J Lipid Res; 2009 May; 50(5):820-31. PubMed ID: 19141871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased 27-hydroxycholesterol production during luteolysis may mediate the progressive decline in progesterone secretion.
    Xu Y; Hutchison SM; Hernández-Ledezma JJ; Bogan RL
    Mol Hum Reprod; 2018 Jan; 24(1):2-13. PubMed ID: 29177442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-talk between TLR4-MyD88-NF-κB and SCAP-SREBP2 pathways mediates macrophage foam cell formation.
    Li LC; Varghese Z; Moorhead JF; Lee CT; Chen JB; Ruan XZ
    Am J Physiol Heart Circ Physiol; 2013 Mar; 304(6):H874-84. PubMed ID: 23335792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Di'ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway.
    Liang J; Li W; Liu H; Li X; Yuan C; Zou W; Qu L
    Front Pharmacol; 2022; 13():857092. PubMed ID: 35571088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.